Research ExplorerScientific StaffBarbara Schmalfeldt Publications

Prof.Dr.med. ID: 2373005

Barbara Schmalfeldt

graph of relations
Affiliations
1 - 50 out of 193Page size: 50

Publications

  1. 2024

  2. Personalised blood pressure management during major noncardiac surgery and postoperative neurocognitive disorders: a randomised trial

    Nicklas, J. Y., Bergholz, A., Däke, F., Pham, H. H. D., Rabe, M-C., Schlichting, H., Skrovanek, S., Flick, M., Kouz, K., Fischer, M., Olotu, C., Izbicki, J. R., Mann, O., Fisch, M., Schmalfeldt, B., Frosch, K-H., Renné, T., Krause, L., Zöllner, C. & Saugel, B., 09.2024, In: BJA Open. 11, p. 100294

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Differences in patterns of sexual assault among female victims preceding and during the COVID-19 pandemic

    Klasen, C. M., Teltrop, L., Belau, M. H., Lohner, L., Ondruschka, B., Riecke, K., Reuter, S., Schmalfeldt, B., Wilmes, S. & Witzel, I., 06.2024, In: FORENSIC SCI MED PAT. 20, 2, p. 595-602 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants

    Riecke, K., Steinhilper, L., von Bülow, C., Schwarz, D., Burandt, E., Striefler, J. K., Müller, V., Schmalfeldt, B. & Witzel, I., 02.2024, In: BREAST CARE. 19, 1, p. 73-76 4 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  5. Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis

    Weigelt, J., Petrosyan, M., Oliveira-Ferrer, L., Schmalfeldt, B., Bartmann, C., Dietl, J., Stürken, C. & Schumacher, U., 08.01.2024, In: BMC CANCER. 24, 1, p. 43

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction

    Marius, W., Leticia, O-F., Friedrich, K-N., Stephan, M., Louisa, H., Tabea, S., Elisa, S., Pauline, W., Yi, D., Qi, M., Barbara, S., Carsten, B., Walter, F., Jasmin, W. & Franziska, B., 2024, In: ONCOIMMUNOLOGY. 13, 1, p. 2346359

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Transcriptome-based identification of key actin-binding proteins associated with high metastatic potential in breast cancer

    Müller, C., Schmalfeldt, B., Müller, V., Schmalfeldt, B. & Windhorst, S., 2024, In: FRONT MOL BIOSCI. 11, p. 1440276

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2023

  9. Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry

    Mandelkow, T., Bady, E., Lurati, M. C. J., Raedler, J. B., Müller, J. H., Huang, Z., Vettorazzi, E., Lennartz, M., Clauditz, T. S., Lebok, P., Steinhilper, L., Woelber, L., Sauter, G., Berkes, E., Bühler, S., Paluchowski, P., Heilenkötter, U., Müller, V., Schmalfeldt, B., von der Assen, A., Jacobsen, F., Krech, T., Krech, R. H., Simon, R., Bernreuther, C., Steurer, S., Burandt, E. & Blessin, N. C., 29.11.2023, In: BIOMEDICINES. 11, 12, 3175.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer

    Volk, A., Legler, K., Hamester, F., Kuerti, S., Eylmann, K., Rossberg, M., Schmalfeldt, B. & Oliveira-Ferrer, L., 11.2023, In: J CANCER RES CLIN. 149, 17, p. 15957-15967 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Kurtz, J-E., Pujade-Lauraine, E., Oaknin, A., Belin, L., Leitner, K., Cibula, D., Denys, H., Rosengarten, O., Rodrigues, M., de Gregorio, N., Martinez García, J., Petru, E., Kocián, R., Vergote, I., Pautier, P., Schmalfeldt, B., Gaba, L., Polterauer, S., Mouret Reynier, M-A., Sehouli, J., Churruca, C., Selle, F., Joly, F., D'Hondt, V., Bultot-Boissier, É., Lebreton, C., Lotz, J-P., Largillier, R., Heudel, P-E., Heitz, F. & ATALANTE/ENGOT-ov29 Investigators, 20.10.2023, In: J CLIN ONCOL. 41, 30, p. 4768-4778 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany

    van der Ven, J., Linz, V. C., Anic, K., Schmidt, M. W., Loewe, A., Krajnak, S., Schmidt, M., Kommoss, S., Schmalfeldt, B., Sehouli, J., Hasenburg, A. & Battista, M. J., 08.2023, In: ARCH GYNECOL OBSTET. 308, 2, p. 527-534 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Impact of Introducing a PACU24 Concept on the Perioperative Outcome of Patients with Advanced Ovarian Cancer Treated with Cytoreductive Surgery

    Reuter, S., Schmalfeldt, B., Haas, S. A., Zapf, A., Cevirme, S., Prieske, K., Wölber, L., Müller, V., Zöllner, C. & Jaeger, A., 08.2023, In: GEBURTSH FRAUENHEILK. 83, 8, p. 1022-1030 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

    Kempska, J., Oliveira-Ferrer, L., Grottke, A., Qi, M., Alawi, M., Meyer, F., Borgmann, K., Hamester, F., Eylmann, K., Rossberg, M., Smit, D. J., Jücker, M., Laakmann, E., Witzel, I., Schmalfeldt, B., Müller, V. & Legler, K., 06.07.2023, In: FRONT ONCOL. 13, p. 1129682 1129682.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer-An Analysis of the NOGGO/JAGO

    Heublein, S., Baum, J., Jaeger, A., Grimm-Glang, D., Olthoff, J., Braicu, E. I., Azzam Nieto, O., Hassdenteufel, K., Schmalfeldt, B., Hanker, L., Wallwiener, M., Schneeweiss, A., Sehouli, J. & Pietzner, K., 29.03.2023, In: CANCERS. 15, 7, 2038.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

    Reimer, F., Bryan, S., Legler, K., Karn, T., Eppenberger-Castori, S., Matschke, J., Pereira-Veiga, T., Wikman, H., Witzel, I., Müller, V., Schmalfeldt, B., Milde-Langosch, K., Schumacher, U., Stürken, C. & Oliveira-Ferrer, L., 16.03.2023, In: CANCER CELL INT. 23, 1, p. 47

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer

    Weidemann, S., Gorbokon, N., Lennartz, M., Hube-Magg, C., Fraune, C., Bernreuther, C., Clauditz, T. S., Jacobsen, F., Jansen, K., Schmalfeldt, B., Wölber, L., Paluchowski, P., Berkes, E., Heilenkötter, U., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Simon, R., Krech, T., Marx, A., Burandt, E. & Lebok, P., 01.02.2023, In: APPL IMMUNOHISTO M M. 31, 2, p. 77-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

    Pfisterer, J., Joly, F., Kristensen, G., Rau, J., Mahner, S., Pautier, P., El-Balat, A., Kurtz, J-E., Canzler, U., Sehouli, J., Heubner, M. L., Hartkopf, A. D., Baumann, K., Hasenburg, A., Hanker, L. C., Belau, A., Schmalfeldt, B., Denschlag, D., Park-Simon, T-W., Selle, F., Jackisch, C., Burges, A., Lück, H-J., Emons, G., Meier, W., Gropp-Meier, M., Schröder, W., de Gregorio, N., Hilpert, F. & Harter, P., 01.02.2023, In: J CLIN ONCOL. 41, 4, p. 893-902 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial

    Pujade-Lauraine, E., Brown, J., Barnicle, A., Wessen, J., Lao-Sirieix, P., Criscione, S. W., du Bois, A., Lorusso, D., Romero, I., Petru, E., Yoshida, H., Vergote, I., Colombo, N., Hietanen, S., Provansal, M., Schmalfeldt, B., Pignata, S., Martín Lorente, C., Berton, D., Runnebaum, I. B. & Ray-Coquard, I., 01.2023, In: JCO PRECIS ONCOL. 7, 7, p. e2200258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

    Brauneck, F., Schmalfeldt, B., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Schulze Zur Wiesch, J., Ding, Y., Qi, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2023, In: FRONT IMMUNOL. 14, p. 1250258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Impact of introducing a PACU24 concept on the perioperative outcome of patients with advanced ovarian cancer treated with cytoreductive surgery

    Reuter, S., Zapf, A., Cevirme, S., Wölber, L., Muller, V., Haas, S. A., Zöllner, C., Schmalfeldt, B. & Jaeger, A. M., 2023, In: INT J GYNECOL CANCER. 33, Suppl 3, 1011.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  22. 2022

  23. Zytoreduktive Chirurgie und hypertherme intraperitoneale Chemoperfusion beim Ovarialkarzinom

    Schmalfeldt, B., 12.2022, In: CHIRURGIE. 93, 12, p. 1144-1151 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  24. Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients

    Oliveira-Ferrer, L., Schmalfeldt, B., Dietl, J., Bartmann, C., Schumacher, U. & Stürken, C., 16.11.2022, In: BIOMEDICINES. 10, 11, 2944.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant

    Wimberger, P., Gerber, M. J., Pfisterer, J., Erdmann, K., Füssel, S., Link, T., du Bois, A., Kommoss, S., Heitz, F., Sehouli, J., Kimmig, R., de Gregorio, N., Schmalfeldt, B., Park-Simon, T-W., Baumann, K., Hilpert, F., Grube, M., Schröder, W., Burges, A., Belau, A., Hanker, L. & Kuhlmann, J. D., 01.11.2022, In: CLIN CANCER RES. 28, 21, p. 4660-4668 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer

    Hamester, F., Stürken, C., Legler, K., Eylmann, K., Möller, K., Roßberg, M., Gorzelanny, C., Bauer, A. T., Windhorst, S., Schmalfeldt, B., Laakmann, E., Müller, V., Witzel, I. & Oliveira-Ferrer, L., 18.10.2022, In: CELLS-BASEL. 11, 20, 3275.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer

    Konrad, S. M., Schwamborn, K., Krüger, A., Honert, K., Schmitt, M., Hellmann, D., Schmalfeldt, B., Meindl, A., Kiechle, M., Quante, A. S., Brambs, C., Grill, S. & Ramser, J., 10.2022, In: BIOMARK MED. 16, 14, p. 1029-1041 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients

    Leffers, M., Herbst, J., Kropidlowski, J., Prieske, K., Bohnen, A. L., Peine, S., Jaeger, A., Prieske, K., Goy, Y., Schmalfeldt, B., Pantel, K., Wölber, L., Effenberger, K. & Wikman, H., 16.08.2022, In: CANCERS. 14, 16, 3954.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. The impact of Enhanced Recovery after Surgery (ERAS) pathways with regard to perioperative outcome in patients with ovarian cancer

    Reuter, S., Woelber, L., Trepte, C. C., Perez, D., Zapf, A., Cevirme, S., Mueller, V., Schmalfeldt, B. & Jaeger, A., 07.2022, In: ARCH GYNECOL OBSTET. 306, 1, p. 199-207 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Frequency of Injuries to Women after Sexual Offense - Relevance of a Gynecology Examination

    Klasen, C. M., Meyer, L., Anders, S., Lohner, L., Ondruschka, B., Pinnschmidt, H., Püschel, K., Schmalfeldt, B., Seifert, D., Wilmes, S. & Witzel, I., 04.2022, In: GEBURTSH FRAUENHEILK. 82, 4, p. 420-426 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer

    Weimer, P., Wellbrock, J., Sturmheit, T., Ferrer, L. O., Ding, Y., Menzel, S., Witt, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Brauneck, F., 11.03.2022, In: CELLS-BASEL. 11, 6, 964.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 6q deletion is frequent but unrelated to patient prognosis in breast cancer

    Lebok, P., Bönte, H., Kluth, M., Möller-Koop, C., Witzel, I., Wölber, L., Paluchowski, P., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Terracciano, L., Krech, R. H., von der Assen, A. & Burandt, E., 03.2022, In: BREAST CANCER-TOKYO. 29, 2, p. 216-223 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Vergote, I., González-Martín, A., Ray-Coquard, I., Harter, P., Colombo, N., Pujol, P., Lorusso, D., Mirza, M. R., Brasiuniene, B., Madry, R., Brenton, J. D., Ausems, M. G. E. M., Büttner, R., Lambrechts, D. & European experts’ consensus group, 03.2022, In: ANN ONCOL. 33, 3, p. 276-287 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  34. Randomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study)

    Maurer, T., Belau, M. H., von Grundherr, J., Schlemmer, Z., Patra, S., Becher, H., Schulz, K-H., Zyriax, B-C., Schmalfeldt, B. & Chang-Claude, J., 23.02.2022, In: BMJ OPEN. 12, 2, e054091.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier

    Hamester, F., Stürken, C., Saygi, C., Qi, M., Legler, K., Gorzelanny, C., Robador, J. R., Schmalfeldt, B., Laakmann, E., Müller, V., Witzel, I. & Oliveira-Ferrer, L., 08.02.2022, In: INT J MOL SCI. 23, 3, 1900.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

    Makker, V., Colombo, N., Casado Herráez, A., Santin, A. D., Colomba, E., Miller, D. S., Fujiwara, K., Pignata, S., Baron-Hay, S., Ray-Coquard, I., Shapira-Frommer, R., Ushijima, K., Sakata, J., Yonemori, K., Kim, Y. M., Guerra, E. M., Sanli, U. A., McCormack, M. M., Smith, A. D., Keefe, S., Bird, S., Dutta, L., Orlowski, R. J., Lorusso, D. & Study 309–KEYNOTE-775 Investigators, 03.02.2022, In: NEW ENGL J MED. 386, 5, p. 437-448 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

    Harter, P., Mouret-Reynier, M. A., Pignata, S., Cropet, C., González-Martín, A., Bogner, G., Fujiwara, K., Vergote, I., Colombo, N., Nøttrup, T. J., Floquet, A., El-Balat, A., Scambia, G., Guerra Alia, E. M., Fabbro, M., Schmalfeldt, B., Hardy-Bessard, A-C., Runnebaum, I., Pujade-Lauraine, E. & Ray-Coquard, I., 02.2022, In: GYNECOL ONCOL. 164, 2, p. 254-264 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome

    Jaeger, A., Prieske, K., Mathey, S., Fischer, I., Vettorazzi, E., Kuerti, S., Reuter, S., Dieckmann, J., Schmalfeldt, B. & Woelber, L., 01.2022, In: ARCH GYNECOL OBSTET. 305, 1, p. 233-240 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients

    Ding, Y., Schmalfeldt, B., Vettorazzi, E., Legler, K., Milde-Langosch, K., Woelber, L., Jaeger, A., Prieske, K., Mueller, V., Schmalfeldt, B. & Kuerti, S., 2022, In: PLOS ONE. 17, 6, e0269680.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2021

  41. Evaluation of a program for routine implementation of shared decision-making in cancer care: results of a stepped wedge cluster randomized trial

    Scholl, I., Hahlweg, P., Lindig, A., Frerichs, W., Zill, J., Cords, H., Bokemeyer, C., Coym, A., Schmalfeldt, B., Smeets, R., Vollkommer, T., Witzel, I., Härter, M. & Kriston, L., 29.12.2021, In: IMPLEMENT SCI. 16, 1, 106.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Transcriptome Analysis in Vulvar Squamous Cell Cancer

    Prieske, K., Alawi, M., Jaeger, A., Wankner, M. C., Eylmann, K., Reuter, S., Lebok, P., Burandt, E., Blessin, N. C., Schmalfeldt, B., Prieske, K., Joosse, S. A. & Woelber, L., 19.12.2021, In: CANCERS. 13, 24, 6372.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer

    Elazezy, M., Prieske, K., Kluwe, L., Oliveira-Ferrer, L., Peine, S., Müller, V., Woelber, L., Schmalfeldt, B., Pantel, K. & Joosse, S. A., 12.2021, In: MOL ONCOL. 15, 12, p. 3615-3625 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer

    Ding, Y., Labitzky, V., Legler, K., Qi, M., Schumacher, U., Schmalfeldt, B., Stürken, C. & Oliveira-Ferrer, L., 12.2021, In: MOL ONCOL. 15, 12, p. 3578-3595 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

    Colombo, N., Dubot, C., Lorusso, D., Caceres, M. V., Hasegawa, K., Shapira-Frommer, R., Tewari, K. S., Salman, P., Hoyos Usta, E., Yañez, E., Gümüş, M., Olivera Hurtado de Mendoza, M., Samouëlian, V., Castonguay, V., Arkhipov, A., Toker, S., Li, K., Keefe, S. M., Monk, B. J. & KEYNOTE-826 Investigators, 11.11.2021, In: NEW ENGL J MED. 385, 20, p. 1856-1867 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. High mitochondrial content is associated with breast cancer aggressiveness

    Lebok, P., Schütt, K., Kluth, M., Witzel, I., Wölber, L., Paluchowski, P., Terracciano, L., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Von Leffern, I., Krech, T., Krech, R. H., Jacobsen, F. & Burandt, E., 10.2021, In: MOL CLIN ONCOL. 15, 4, 203.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer

    Rico, S. D., Schmalfeldt, B., Müller, V., Wölber, L., Witzel, I., Paluchowski, P., von Leffern, I., Heilenkötter, U., Jacobsen, F., Bernreuther, C., Clauditz, T., Simon, R., Steurer, S., Burandt, E., Marx, A. H. & Krech, T., 08.2021, In: PATHOL RES PRACT. 224, 153533.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

    Hoyer, H., Mehlhorn, G., Scheungraber, C., Hagemann, I., Hirchenhain, C., Woelber, L., Stolte, C., Hampl, M., Scherbring, S., Denecke, A., Bartels, J., Ebert, A. D., Meneder, S., Petzold, A., Heller, T., Heidtke, K. R., Schwarz, E., Stübs, F., Schütze, S., Stange, E-L., Jaeger, A., Martignoni, F., Dellmann, A., Rody, A., Hillemanns, P., Fehm, T., Petry, K-U., Böhmer, G., Schmalfeldt, B., Wimberger, P., Beckmann, M. W., Runnebaum, I. B. & Dürst, M., 01.07.2021, In: CANCERS. 13, 13, 3309.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Asbestos Exposure and Ovarian Cancer - a Gynaecological Occupational Disease. Background, Mandatory Notification, Practical Approach

    Nowak, D., Schmalfeldt, B., Tannapfel, A. & Mahner, S., 05.2021, In: GEBURTSH FRAUENHEILK. 81, 5, p. 555-561 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  50. Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany

    Grimm, D., Mathes, S., Woelber, L., Van Aken, C., Schmalfeldt, B., Mueller, V., Kiechle, M., Brambs, C. & Paepke, D., 05.2021, In: ARCH GYNECOL OBSTET. 303, 5, p. 1315-1330 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany

    Grimm, D., Voiss, P., Paepke, D., Dietmaier, J., Cramer, H., Kümmel, S., Beckmann, M. W., Woelber, L., Schmalfeldt, B., Freitag, U., Kalder, M., Wallwiener, M., Theuser, A-K. & Hack, C. C., 04.2021, In: ARCH GYNECOL OBSTET. 303, 4, p. 967-980 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC)

    Woelber, L., Mathey, S., Prieske, K., Kuerti, S., Hillen, C., Burandt, E., Coym, A., Mueller, V., Schmalfeldt, B. & Jaeger, A., 16.03.2021, In: ONCOL RES. 28, 6, p. 645-659 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  53. The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study

    Seiffert, K., Thoene, K., Eulenburg, C. Z., Behrens, S., Schmalfeldt, B., Becher, H., Chang-Claude, J. & Witzel, I., 02.2021, In: BREAST. 55, p. 98-104 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients

    Heinze, K., Rengsberger, M., Gajda, M., Jansen, L., Osmers, L., Oliveira-Ferrer, L., Schmalfeldt, B., Dürst, M., Häfner, N. & Runnebaum, I. B., 22.01.2021, In: CLIN EPIGENETICS. 13, 1, p. 15

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next